Island Pharmaceuticals Ltd - ESG Rating & Company Profile powered by AI
Full ESG analysis of Island Pharmaceuticals Ltd can be accessed by logging in. If you are employed by Island Pharmaceuticals Ltd and you would like to use your ESG rating, please contact us. This Sustainability score for Island Pharmaceuticals Ltd indicates its reporting of the UN SDGs.
Island Pharmaceuticals Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Island Pharmaceuticals Ltd | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Island Pharmaceuticals Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd report the average age of the workforce?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd offer flexible work?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd conduct supply chain audits?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Island Pharmaceuticals Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose water use targets?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Island Pharmaceuticals Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Island Pharmaceuticals Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Island Pharmaceuticals Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose its waste policy?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose energy use targets?
Sign up for free to unlockDoes Island Pharmaceuticals Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Island Pharmaceuticals Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Island Pharmaceuticals Ltd
These potential risks are based on the size, segment and geographies of the company.
Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. The company has a research collaboration agreement with Monash University to screen known molecules against host targets; research and development collaboration with Griffith University to screen for active anti-viral molecules in a rational repurposing strategy; and research collaboration agreement with Compounds Australia, a drug library containing approximately four and a half thousand molecules that could be searched for drug re-purposing and pipeline development. It also has a cooperative research and development agreement with the U.S. Army in preparation for its Phase II clinical study for ISLA-101; supply agreement with Catalent for manufacture of Fenretinide softgels for dengue fever trial participants; and right to reference National Cancer Institute IND for Isla101. The company was founded in 2017 and is based in Camberwell, Australia.